---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-23-009150"
form_type: "8-K"
ticker: "SNOA"
cik: "0001367083"
company_name: "Sonoma Pharmaceuticals, Inc."
filed_at: "2023-12-29T23:59:59+00:00"
generated_at: "2026-06-07T05:46:48.468103+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Sonoma Pharmaceuticals grants 180,000 stock options to executive officers at $0.18 per share

## Summary
- CEO Amy Trombly, interim CFO Jerry Dvonch, and COO Bruce Thornton each received 60,000 options.
- Exercise price of $0.18 is based on December 29, 2023 closing price.
- Options vest in three equal annual tranches; non-employee directors waived their grants.
- All options fully vest upon a change of control.
- Total options granted to executive officers: 180,000.

## SEC filing metadata
- accession: 0001683168-23-009150
- form_type: 8-K
- ticker: SNOA
- cik: 0001367083
- company_name: Sonoma Pharmaceuticals, Inc.
- filed_at: 2023-12-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1367083/000168316823009150/0001683168-23-009150-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1367083/000168316823009150/sonoma_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-23-009150
- JSON: https://secwatch.observer/filing/0001683168-23-009150.json
- Plain text: https://secwatch.observer/filing/0001683168-23-009150.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.